Yu Fan
CENTRAL, HONG KONG, K3
$108m in 8 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 20.2% of the portfolio this quarter.
Value
$108m
Stocks
8
Top 10 share
100.0%
Turnover
20.2%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
- Whitehawk TherapeuticsWHWK20.6% of the fund+135%
Cut
Sold some of their stake.
- AlumisALMS6.6% of the fund-67%
- CeribellCBLL6.2% of the fund-38%
Sold out
Sold their entire stake.
None this quarter.
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Kestra Medical TechnologiesKMTS | 53.8% | $58m | 2,282,519 | Held |
| Whitehawk TherapeuticsWHWK | 20.6% | $22m | 4,861,314 | +135% |
| AlumisALMS | 6.6% | $7m | 252,672 | -67% |
| CeribellCBLL | 6.2% | $7m | 342,398 | -38% |
| InventivaIVA | 5.3% | $6m | 1,500,000 | Held |
| ProMIS NeurosciencesPMN | 4.0% | $4m | 329,760 | Held |
| Perspective TherapeuticsCATX | 3.3% | $4m | 1,055,409 | Held |
| American BitcoinABTC | 0.2% | $209,831 | 308,076 | Held |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 47.5% since 30 June 2025.
Where the money is
Health care99.8%
Financial services0.2%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.